No increased cancer risk with glargine versus human insulin
(HealthDay)—There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study ...
Aug 6, 2013
0
0